As the clock ticks down to 2027, thousands of New York seniors are bracing for a significant increase in their prescription drug costs. A critical subsidy program, which has been helping low-income seniors pay for their medications, is set to expire next year, leaving many vulnerable individuals struggling to afford life-saving treatments. The program, which has been in place for over a decade, has provided crucial financial assistance to seniors who rely on costly medications to manage chronic conditions such as diabetes, hypertension, and cancer. Without this support, many New Yorkers will be forced to choose between paying for their medications or other essential expenses, highlighting a pressing concern about the accessibility of healthcare for the state's most vulnerable population.
New York seniors face higher drug premiums as subsidy ends in 2027 PIX11
